Trial Profile
The efficacy of entecavir and telbivudine in HBeAg positive chronic hepatitis B patients with high viral load
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2012
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 21 May 2012 Actual end date (8 Dec 2010) added as reported by Chinese Clinical Trial Register.
- 12 Dec 2011 New trial record